Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indication
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indication
Authors
Keywords
-
Journal
STATISTICAL METHODS IN MEDICAL RESEARCH
Volume -, Issue -, Pages 096228022210919
Publisher
SAGE Publications
Online
2022-04-11
DOI
10.1177/09622802221091901
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current statistical considerations and regulatory perspectives on the planning of confirmatory basket, umbrella and platform trials
- (2020) Olivier Collignon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Bayesian basket trial design using a calibrated Bayesian hierarchical model
- (2018) Yiyi Chu et al. Clinical Trials
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utilizing Real-World Data to Inform a Confirmatory Basket Trial Design: Studying Use of Rituximab in Autoimmune Diseases
- (2018) D Guinn et al. VALUE IN HEALTH
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
- (2017) Vinay Prasad et al. JAMA Internal Medicine
- Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker
- (2016) RA Beckman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Bayesian basket design for genomic variant-driven phase II trials
- (2016) Richard Simon et al. SEMINARS IN ONCOLOGY
- A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines
- (2016) Kristen M. Cunanan et al. STATISTICS IN MEDICINE
- Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study
- (2016) Cong Chen et al. Statistics in Biopharmaceutical Research
- The Impact of Adaptive Design on Portfolio Optimization
- (2016) Zoran Antonijevic Therapeutic Innovation & Regulatory Science
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maximizing Return on Socioeconomic Investment in Phase II Proof-of-Concept Trials
- (2014) C. Chen et al. CLINICAL CANCER RESEARCH
- Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
- (2013) Scott M Berry et al. Clinical Trials
- Integrating predictive biomarkers and classifiers into oncology clinical development programmes
- (2011) Robert A. Beckman et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started